Snapshot Camera for AMD

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · May 24, 2019

Keywords

ClinConnect Summary

This clinical trial, called "Snapshot Camera for AMD," is exploring a new technology that helps doctors see the back of the eye more clearly, specifically looking at a part called the retinal pigment epithelium (RPE). This is particularly important for people with age-related macular degeneration (AMD), a condition that can affect vision as we get older. While there isn't a cure for AMD yet, catching the disease early can help slow down vision loss. The new imaging method being tested combines different techniques to provide detailed pictures of the retina, which could help in diagnosing and understanding AMD better.

To participate in this study, you need to be 60 years or older and have a specific type of AMD in at least one eye. You also need to have had cataract surgery (which means your lens has been replaced) and be able to have your eyes dilated for the test. However, if you have other eye diseases besides AMD or severe AMD in both eyes, you might not be eligible. If you join the study, you can expect to undergo a special eye exam with this new camera technology, which could help improve how we diagnose and manage AMD in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must be aged 60 and over and pseudophakic, with clear posterior capsule and dilation to 6mm.
• • Patients must be diagnosed early/intermediate AMD in at least one eye (the study eye) with soft drusen or reticular pseudodrusen in the macula.
• Exclusion Criteria:
• • Retinopathy other than AMD.
• • Inability to give informed consent
• • Bilateral advanced AMD
• • Allergy to dilation eye drops